The costs to patients, their families, their workplaces, and their communities go well beyond dollars and cents.
|Podcasts|May 30, 2023
Pharmacy Focus: Student Edition - Creatives in Pharmacy
Sue Ojageer discusses the new coloring book she created to explore different pharmaceutical career paths.
Advertisement
On this episode, we spoke with Sue Ojageer, PharmD, a clinical pharmacist and STEM children's book writer, about a new coloring book she created to explore different pharmaceutical career paths.
Advertisement
Related to this article
The approval is supported by findings from the phase 3 OCEANIC-STROKE trial.
Pharmacy Times previews enlicitide, survodutide, diet and heart failure risk, and pharmacist-led HF care ahead of the AHA Scientific Sessions in Chicago.
Garlic has a long history in traditional medicine, but evidence for its benefits varies by preparation, and patients taking medications that increase bleeding risk should use it with caution.
About 89% of Americans live within 5 miles of a pharmacy, but proximity says little about whether they can afford their medications or get real counseling.
Across every setting, the pharmacist's role is to build reliable systems around patients so stroke prevention remains safe and sustainable across the care continuum.
Adding the IL-15 agonist to frontline BCG improved responses in carcinoma in situ without new safety signals; full data are expected at an upcoming congress.
Getting patients vaccinated matters more than which COVID-19 vaccine they receive, says Jodi Longueil, PharmD.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Requires Class-Wide GLP-1 RA Labeling Changes for Potential NAION Risk
2
Oral PCSK9 Inhibitor Enlicitide Sustains LDL-C Reductions
3
mRNA vs Protein-Based COVID-19 Vaccines: What Pharmacists Can Tell Patients
4
Asundexian Receives FDA Approval, Becomes First FXIa Inhibitor for Secondary Stroke Risk Reduction
5